1. Government Regulatory Agencies and Impact on Consumer Choices Presentation

2. Division of Drug Marketing, Advertisement, and Communications (DDMAC) A department under the Food and Drug Administration Knowledge, Implementation, and Regulatory Plans Investigation and Qualitative Studies

3. Functions of DDMAC Accountable for Safeguarding the Community’s Wellbeing in the US Ensures Truthful and Precise Brand Messaging about Medicines Manages Branding and Advertising Data Makes Inspections

4. Healthcare Goods and Services Managed by the Agency Prescription drug promotions Brand naming

5. Detailed Healthcare Services Bad Ad Program Allows medical practitioners to learn inaccurate prescription drug advertising. Allows medical practitioners to give an account to breach in adverstising to the DDMAC.

6. Three Benefits of Regulatory Lapses for Patients Management of what facts are imparted to the patients. Concentration in consumer wellbeing of goods that are accessible to the pateints. Regulatory Lapses as to the prohibiting deceptive info to the patients.

7. Three Benefits of Regulatory Lapses for Healthcare Practitioners Decreasing the dangers of hazardous medical goods that are circulated. Policy administration in management of liability with pharmacy systems. Uphold integrity between healthcare providers and patients, in addition to the general healthcare market in the patients’ point of view.

8. The DDMACThe DDMAC Ensures that the info contained in promo ads are accurate or deceiving patients by any means. Has a careful surveillance, assessment, implementation, and training plans to safeguard and teach the individuals Because of the improvements and accurate message in branding and advertising information influences both the patients and the medical service provider. How the Function of the Agency Influences Patients’ Preferences in Marketing

9. Healthcare Spending for Patients

10. Aspects that Influence Patient's Choice of Healthcare Practioner

11. Conclusion The Reasons for Establishing the DDMAC Safeguard individuals from consuming harmful drugs. Gives medical practitioners the capability to be familiar with deceptive prescription drugs. Provide good communication in branding and advertising info to patients and medical service providers. Conduct inspections to promote wellbeing of Americans

12. References Food and Drug Administration (2010). Division of Drug, Marketing, Advertising, and Communications. Retrieved from http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm 090142.htm Okie, S. “What Ails the FDA?” New England Journal of Medicine; 2005;352:1063-1066 U.S. Department of Health & Human Services. Key Points of FDA Healthcare Professional Outreach (Bad Ad Program). 2010. Retrieved from http://www.fda.gov/Drugs/GuidanceComplianceRegulator yInformation/Surveillance/DrugMarketingAdvertisingand Communications/ucm211498.htm